USPTO serial 79330778
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Erica Halstead
Erica Halstead Womble Bond Dickinson (US) LLP950 Third Ave.Suite 2400New York, NY 10022| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of cardiovascular disorders and metabolic disorders; pharmaceutical preparations for the treatment of glaucoma and ocular hypertension; pharmaceutical preparations for the treatment of corneal endothelial disorder; sanitary preparations for medical use; pharmaceutical preparations for the treatment of conditions and diseases of the circulatory system; pharmaceutical preparations for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders; antivirals for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders; adhesive plasters for medical purposes, namely, for protecting joints during exercise, sports or rehabilitation from injury; hand-sanitizing preparations; antimicrobials for dermatologic use; disinfectants for sanitary purposes; fumigating apparatus as disinfectants for domestic use for non-medical purposes; pharmaceutical and biological preparations for the treatment of diseases of the central nervous system, peripheral nervous system, sensory organs, the circulatory system, respiratory system, and the digestive system; pharmaceutical substances for the treatment of dermatological diseases, allergies and urogenital or anal conditions; pharmaceutical preparations, namely, amino acid for medical or veterinary purposes; pharmaceutical preparations for the prevention and treatment of disorders of the metabolic system; topical and oral antibiotics; pharmaceutical preparations for use in chemotherapy; drug delivery agents in the form of capsules, solvents or gels that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; chemotherapeutic agents having antineoplastic activity; crude drugs, namely, medicines made of rootstock, bark, leaves, fruits, seeds, rhinoceros' horn, musk or bear's gall, used for the treatment of pain, cold, fever, anemia, and for diuretics, astringents; antibiotic preparations for human use; absorbent cotton for medical purposes; adhesive plasters for sanitary purposes; bandages for dressings; anti-inflammatory agents, namely, topical preparations in the form of gels and salves, adhesive skin patches, liquid formulations, cream and sprays, all for relieving pain; analgesics | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 31, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 11, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 11, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 21, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 11, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 21, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Mar 21, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 3, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 3, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 14, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 23, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 9, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 9, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 9, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 12, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 10, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 10, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 29, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 28, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 24, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 1, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 27, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 20, 2022 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Jan 6, 2022 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |